SPC212
Sarílúmab
Status:
VeittApplication date:
15.11.2017Application published:
15.12.2017Grant published:
15.5.2019
Max expiry date:
31.5.2032Medicine name:
KevzaraMedicine for children:
No
Timeline
Today
15.11.2017Application
15.12.2017Publication
15.5.2019Registration
31.5.2032Expires
Marketing license
IS authorization number:
EU/1/17/1196/005-006; EU/1/17/1196/007-008Date:
14.7.2017
Foreign authorization number:
EU/1/17/1196Date:
23.6.2017
Owner
Name:
REGENERON PHARMACEUTICALS, INC.Address:
777 Old Saw Mill River Road, Tarrytown, NY US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2041177